Hi Alison,
Manitoba Renal Program decided to avoid the 1500 mg dose on our preprinted orders. We surveyed renal pharms across Canada and no one seems to be giving the higher dose as of yet, even in non-renal patients. This dose was not given in the published CKD trials. Also the 2 ongoing US trials (FERWON-2 CKD and FERWON-3 IDA/CKD) use a single dose of 1000 mg.
However, can certainly understand wanting to limit outpatient visits in light of COVID-19.
Lori Wazny, Pharm.D.
